Determination of solifenacin in human plasma by liquid chromatography-tandem mass spectrometry

被引:17
作者
Macek, Jan [1 ]
Ptacek, Pavel [1 ]
Klima, Josef [1 ]
机构
[1] Pharmakl SRO, CZ-15800 Prague 13, Czech Republic
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2010年 / 878卷 / 31期
关键词
Solifenacin; HPLC; LC-MS/MS; Plasma; Pharmacokinetics; PHARMACOKINETICS; SUCCINATE;
D O I
10.1016/j.jchromb.2010.10.010
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A liquid chromatography-electrospray tandem mass spectrometry method was developed and validated to quantitate solifenacin in human plasma The assay was based on protein precipitation with methanol and liquid chromatography performed on a pentafluorophenylpropylsilica column (50 x 4 mm 3 mu m particles) the mobile phase consisted of methanol - 100 mM ammonium acetate containing 1% of formic acid (90 10 v/v) Quantification was through positive-ion mode and selected reaction monitoring at m/z 363 -> 193 and 368 -> 198 for solifenacin and the internal standard solifenacin-D-5 respectively The lower limit of quantitation was 0 47 ng/ml using 0 25 ml of plasma and linearity was demonstrated up to 42 ng/ml Intra-assay and inter-assay precision expressed by relative standard deviation was less than 11% and inaccuracy did not exceed 11% at all levels The assay was applied to the analysis of samples from a pharmacokinetic study (C) 2010 Elsevier B V All rights reserved
引用
收藏
页码:3327 / 3330
页数:4
相关论文
共 6 条
[1]   Clinical Pharmacokinetics and Pharmacodynamics of Solifenacin [J].
Doroshyenko, Oxana ;
Fuhr, Uwe .
CLINICAL PHARMACOKINETICS, 2009, 48 (05) :281-302
[2]   Highly sensitive and rapid LC-ESI-MS/MS method for the simultaneous quantification of uroselective α1-blocker, alfuzosin and an antimuscarinic agent, solifenacin in human plasma [J].
Mistri, Hiren N. ;
Jangid, Arvind G. ;
Pudage, Ashutosh ;
Rathod, Dhiraj M. ;
Shrivastav, Pranav S. .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2008, 876 (02) :236-244
[3]   Solifenacin in overactive bladder syndrome [J].
Payne, CK .
DRUGS, 2006, 66 (02) :175-190
[4]   Pharmacokinetics and safety of solifenacin succinate in healthy young men [J].
Smulders, RA ;
Krauwinkel, WJ ;
Swart, PJ ;
Huang, M .
JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 44 (09) :1023-1033
[5]   Pharmacokinetic effect of ketoconazole on solifenacin in healthy volunteers [J].
Swart, Pieter J. ;
Krauwinkel, Walter J. J. ;
Smulders, Ronald A. ;
Smith, Neila N. .
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2006, 99 (01) :33-36
[6]   Determination of solifenacin succinate, a novel muscarinic receptor antagonist, and its major metabolite in rat plasma by semi-micro high performance liquid chromatography [J].
Yanagihara, Takamitsu ;
Aoki, Toshiko ;
Soeishi, Yoshiaki ;
Watsubo, Takafumi ;
Kamimura, Hidetaka .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2007, 859 (02) :241-245